lunes, 13 de abril de 2020

Unreported clinical trial results: lost opportunities for FDA, NIH - STAT

Unreported clinical trial results: lost opportunities for FDA, NIH - STAT

The Readout

Damian Garde & Meghana Keshavan

More reads

  • Lost opportunities from FDA, NIH inaction when sponsors fail to report clinical trial results. (STAT)
  • FDA greenlights blood detox device to combat COVID-19's cytokine storms. (FierceBiotech)

No hay comentarios: